DIAGNOS (CVE:ADK) Hits New 12-Month High – Here’s Why

DIAGNOS Inc. (CVE:ADK)’s stock price hit a new 52-week high on Wednesday . The stock traded as high as C$0.42 and last traded at C$0.40, with a volume of 183300 shares traded. The stock had previously closed at C$0.39.

DIAGNOS Stock Up 3.8%

The company has a current ratio of 1.49, a quick ratio of 0.68 and a debt-to-equity ratio of 204.05. The business’s fifty day moving average price is C$0.27 and its 200 day moving average price is C$0.26. The company has a market capitalization of C$48.77 million, a P/E ratio of -10.12 and a beta of -0.14.

Insider Activity

In related news, Director Robert Dunn bought 200,000 shares of the company’s stock in a transaction dated Wednesday, July 29th. The stock was acquired at an average cost of C$0.30 per share, with a total value of C$60,000.00. Following the acquisition, the director owned 2,117,778 shares in the company, valued at approximately C$635,333.40. This represents a 10.43% increase in their position. Over the last ninety days, insiders purchased 328,571 shares of company stock valued at $96,000. Corporate insiders own 16.81% of the company’s stock.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.